Although the pharmaceutical market has calmed down somewhat and COVID-19 has become a part of the new normal, this article looks back at the beginning of the pandemic. In addition to the recent national changes in the prescription (Rx), over-the-counter (OTC), and medical device markets, significant regional differences are also evident. These are due to widely varying infection rates, differing age demographics, and, in particular, access to medications. Finally, the vaccine market continues to be significantly impacted by the effects of COVID-19.

Read more